The present study aims at the improvement of the treatment of adults with treatment-refractory PTSD with an open clinical study examining the effectiveness and feasibility of a brief intensive exposure treatment.
ID
Bron
Aandoening
Post-Traumatic Stress Disorder (PTSD)
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
PTSD symptom severity: <br>
- CAPS<br>
- PSS-SR
Achtergrond van het onderzoek
The present study aims to examine the effectiveness and feasibility of an outpatient brief intensive exposure treatment for treatment-refractory complex PTSD patients. The new treatment program makes use of proven effective therapy techniques in processing the trauma and decreasing PTSD symptoms, whereas the delivery of the treatment is using a new format: 4 days (spread over two weeks).
Country of Recruitment: The Netherlands
Doel van het onderzoek
The present study aims at the improvement of the treatment of adults with treatment-refractory PTSD with an open clinical study examining the effectiveness and feasibility of a brief intensive exposure treatment.
Onderzoeksopzet
All measures:
- before treatment (baseline: A0);
- seven weeks after baseline (post
treatment: A1);
- 18 weeks after baseline (follow up 1: A2);
- and 30 weeks after baseline (follow up 2:
A3).
PSS-SR:
- time points as defined above;
- as well as in week 3,4,5 and 6 (before follow up appointments).
Onderzoeksproduct en/of interventie
Brief intensive exposure treatment:
4 days (spread over two weeks), offered in three blocks of 90 minutes each day and four follow up appointments (90 minutes each).
Publiek
Tarweweg 2
A. Minnen, van
Nijmegen 6534 AM
The Netherlands
024-3837820
avminnen@ggznijmegen.nl.
Wetenschappelijk
Tarweweg 2
A. Minnen, van
Nijmegen 6534 AM
The Netherlands
024-3837820
avminnen@ggznijmegen.nl.
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
(1) Age ≥ 18 years.
(2) History of multiple interpersonal traumas.
(3) Meeting full DSM-IV diagnostic criteria of PTSD established through the Clinical-Administered PTSD Scale (CAPS).
(4) Lack of treatment response during regular PTSD guideline treatment.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
(1) Suicide attempt within 8 weeks prior to study entry.
(2) Inability to speak and write Dutch.
(3) Severe intellectual impairment (IQ≤ 70)
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5576 |
NTR-old | NTR5931 |
Ander register | Innovatiefonds Zorgverzekeraars : 2335 |